Hydroxyurea Treatment in Transfusion-Dependent β-Thalassemia Patients

BACKGROUND: β-Thalassemia is an inherited hemoglobin disorder caused by defective synthesis of ß-globin chains. Hemoglobin (Hb) F induction is a possible therapeutic approach which can partially compensate for α and non-α globin chains imbalance. OBJECTIVES: We aimed to investigate the efficacy and...

Descrición completa

Gardado en:
Detalles Bibliográficos
Main Authors: Bordbar, Mohammad Reza, Silavizadeh, Samir, Haghpanah, Sezaneh, Kamfiroozi, Roza, Bardestani, Marzieh, Karimi, Mehran
Formato: Artigo
Idioma:Inglês
Publicado: Kowsar 2014
Assuntos:
Research Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC4102988/
https://ncbi.nlm.nih.gov/pubmed/25068055
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5812/ircmj.18028
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares